Grant: CIHR Fellowship
Direct Payment
$129,167.00
Developing an optogenetically-inspired deep brain stimulation protocol to normalize synaptic transmission and abolish pathological behaviour in a SAPAP3 knock-out model of obsessive-compulsive disorder
EF 2014-15
Résumé
Circuit dysfunction resulting from pathological forms of synaptic plasticity underlies several psychiatric diseases, including obsessive compulsive disorder (OCD). OCD is a debilitating disorder characterized by intrusive thoughts (obsessions) and repetitive actions (compulsions) performed to relieve the anxiety accompanying the obsessions. Dysfunction of neuronal circuitry between the cortex and striatum is implicated in OCD-spectrum disorders by human imaging and genetic association studies, and by animal models. The synaptic protein SAPAP3 , has been implicated in OCD. Mice in which SAPAP3 has been deleted exhibit excessive grooming and anxiety, and are used to model OCD spectrum disorders. These mice also show decreased neuronal transmission from cortex onto the striatum, a brain structure critical for the expression of normal motor behaviours. Deep brain stimulation (DBS) is a promising surgical therapy for OCD, although its effects are mediated by mechanisms that are largely unknown. Moreover, the effects of DBS are transient, requiring life-long stimulation. Using optogenetics, a technique that allows us to tightly control the activity of neurons using light-delivery through fiberoptics implanted in the brain, we can apply acute (10 minute) stimulation protocols that have long-lasting effects on neuronal transmission and behaviour. However, applying optogenetics in humans is limited by viral transfection strategies and effective light delivery, and will not be a viable treatment for human patients in the immediate future. To circumvent these limitations, we will develop a DBS protocol that can also rescue depressed neuronal transmission in SAPAP3 knock-out mice, and consequently abolish associated OCD-like behaviours in these mice. There is currently no universally effective therapy for OCD; a DBS protocol which has long-term effects and works through an established mechanism of action would be a major advance in the clinical treatment of OCD.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Switzerland
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318680
Name
Creed Meaghan
Country
Switzerland
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Developing an optogenetically-inspired deep brain stimulation protocol to normalize synaptic transmission and abolish pathological behaviour in a SAPAP3 knock-out model of obsessive-compulsive disorder
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$129,167
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Channelrhodopsin; Deep Brain Stimulation; Dopamine; Glutamate; In Vivo Electrophysiology; Obsessive Compulsive Disorder; Optogenetics; Patch Clamp Electrophysiology; Sapap3; Synaptic Plasticity
Abstract
Circuit dysfunction resulting from pathological forms of synaptic plasticity underlies several psychiatric diseases, including obsessive compulsive disorder (OCD). OCD is a debilitating disorder characterized by intrusive thoughts (obsessions) and repetitive actions (compulsions) performed to relieve the anxiety accompanying the obsessions. Dysfunction of neuronal circuitry between the cortex and striatum is implicated in OCD-spectrum disorders by human imaging and genetic association studies, and by animal models. The synaptic protein SAPAP3 , has been implicated in OCD. Mice in which SAPAP3 has been deleted exhibit excessive grooming and anxiety, and are used to model OCD spectrum disorders. These mice also show decreased neuronal transmission from cortex onto the striatum, a brain structure critical for the expression of normal motor behaviours. Deep brain stimulation (DBS) is a promising surgical therapy for OCD, although its effects are mediated by mechanisms that are largely unknown. Moreover, the effects of DBS are transient, requiring life-long stimulation. Using optogenetics, a technique that allows us to tightly control the activity of neurons using light-delivery through fiberoptics implanted in the brain, we can apply acute (10 minute) stimulation protocols that have long-lasting effects on neuronal transmission and behaviour. However, applying optogenetics in humans is limited by viral transfection strategies and effective light delivery, and will not be a viable treatment for human patients in the immediate future. To circumvent these limitations, we will develop a DBS protocol that can also rescue depressed neuronal transmission in SAPAP3 knock-out mice, and consequently abolish associated OCD-like behaviours in these mice. There is currently no universally effective therapy for OCD; a DBS protocol which has long-term effects and works through an established mechanism of action would be a major advance in the clinical treatment of OCD.
Competitiondate
201411
Approvedterm2
2 yrs 7 mths
Pinamesdelim
Creed, Meaghan
Approvedterm
2 ans 7 mois
Cihrcontribution2
~ $129,167~ $0~